Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H18FNO2 |
| Molecular Weight | 395.425 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(CN2C=C(C(=O)OC3=CC=CC4=CC=CC=C34)C5=C2C=CC=C5)C=C1
InChI
InChIKey=RCEKSVIFQKKFLS-UHFFFAOYSA-N
InChI=1S/C26H18FNO2/c27-20-14-12-18(13-15-20)16-28-17-23(22-9-3-4-10-24(22)28)26(29)30-25-11-5-7-19-6-1-2-8-21(19)25/h1-15,17H,16H2
| Molecular Formula | C26H18FNO2 |
| Molecular Weight | 395.425 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P21554|||Q5UB37 Gene ID: 1268.0 Gene Symbol: CNR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655 |
1.19 nM [Ki] | ||
Target ID: P34972 Gene ID: 1269.0 Gene Symbol: CNR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655 |
2.43 nM [Ki] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:22:46 GMT 2025
by
admin
on
Mon Mar 31 23:22:46 GMT 2025
|
| Record UNII |
85E88884ZQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-FDU-PB-22
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FDU-PB-22
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY | Several cannabimimetic quinolinyl carboxylates (PB-22, Item No. 14096 and BB-22, Item No. 14099) and cannabimimetic carboxamide derivatives (ADB-FUBINACA, Item No. 14292 and ADBICA, Item No. 14293) have been identified as designer drugs in illegal products.1 FDU-PB-22 is a derivative of PB-22 in which the pentyl side chain is replaced by a 4-fluorobenzyl group, a functional group also found in indazole-based synthetic cannabinoids such as ADB-FUBINACA. Additionally, the 8-quinolinol is replaced by a naphthalene group, similar to the structure of AM2201 (Item No. 10707).2,3,1 The physiological and toxicological properties of this compound are not known. | ||
|
1883284-94-3
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY | |||
|
FDU-PB-22
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY | FDU-PB-22 is an derivative of JWH-018 that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a "legal high". FDU-PB-22 is a controlled substance in Germany and is banned in Japan and Sweden. | ||
|
119025888
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY | |||
|
DTXSID901016910
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY | |||
|
85E88884ZQ
Created by
admin on Mon Mar 31 23:22:46 GMT 2025 , Edited by admin on Mon Mar 31 23:22:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |